Implications of clinical trial design on sample size requirements

Schizophrenia Bulletin

Volumn 34, Issue 4, 2008, Pages 664-669

  Leon, Andrew C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Multiplicity; Reliability; Sample size; Statistical power

Indexed keywords

CLINICAL RESEARCH; COGNITION; EXPERIMENTAL DESIGN; HUMAN; PRIORITY JOURNAL; RELIABILITY; REVIEW; SAMPLE SIZE; SCHIZOPHRENIA; STATISTICAL ANALYSIS;

COGNITION DISORDERS; CONTROL GROUPS; DOUBLE-BLIND METHOD; ETHICS, RESEARCH; HUMANS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REACTION TIME; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE; SCHIZOPHRENIA; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 46849117060     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn035     Document Type: Review

References (21)

1. Leon AC, Mallinckrodt CH, Chuang-Stein C, Archibald DG, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biol Psychiatry. 2006;59:1001-1005.
2. American Statistical Association. Ethical Guidelines for Statistical Practice 1999;http://www.amstat.org/profession/index.-cfm?fuseaction= ethicalstatistics. Accessed December 29, 2007.
3. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry. 2006;59:990-996.
4. Cohen J. A power primer. Am Psychol. 1992;112:155-159.
5. Lehr R. 16 s-squared over d-squared: a relation for crude sample size estimates. Stat Med. 1992;11:1099-1102.
6. Leon AC, Marzuk PM, Portera L. More reliable outcome measures can reduce sample size requirements. Arch Gen Psychiatry. 1995;52:867-871.
7. Fleiss JL. The Design & Analysis of Clinical Experiments. New York, NY: John Wiley and Sons; 1986.
8. Kobak K, DeBrota D, Engelhardt N, Williams J. Site vs. Centralized Raters in an MDD RCT. Presented at: the NIMH New Clinical Drug Evaluation Unit (NCDEU); 2006; Boca Raton, FL.
9. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavge JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006;63:484-489.
10. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, Part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203-213.
11. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc [SerB], 1995;57:289-300.
12. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for Industry: E9 Statistical Principles for Clinical Trials. September, 1998 (page 9). www.fda.gov/cder/guidance/ICH_E9-fnl. PDF. Accessed December 31, 2007.
13. Ury HK. A comparison of four procedures for multiple comparisons among means (pairwise contrasts) for arbitrary sample sizes. Technometrics. 1976;18:89-97.
14. Leon AC. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power when using the Bonferroni adjustment. J Clin Psychiatry. 2004;65:1511-1514.
15. Barch DM, Yodkovik N, Sypher-Locke H, Hanewinkel M. Intrinsic motivation in schizophrenia: Relationships to cognitive function, depression, anxiety and personality. Journal of Abnormal Psychology. In press.
16. Pocock SJ, Geller NL, Tsiatis AA. The analysis of multiple endpoints in clinical trials. Biometrics. 1987;43:487-498.
17. Leon AC, Heo M. A comparison of multiplicity adjustment strategies for correlated binary endpoints. J Biopharm Stat. 2005;15:839-855.
18. James S. The approximate multinormal probabilities applied to correlated multiple endpoints in clinical trials. Stat Med. 1991;10:1123-1135.
19. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75:800-803.
20. Lieberman JA, Stroup TS, McEvoy JP, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
21. Leon AC, Heo M, Teres JJ, Morikawa T. Statistical power of multiplicity adjustment strategies for correlated binary endpoints. Stat Med. 2007;26:1712-1726.